Editas Medicine (EDIT) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to 0.07.
- Editas Medicine's Equity Ratio fell 8756.36% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year decrease of 8756.36%. This contributed to the annual value of 0.39 for FY2024, which is 4379.49% down from last year.
- Latest data reveals that Editas Medicine reported Equity Ratio of 0.07 as of Q3 2025, which was down 8756.36% from 0.09 recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Equity Ratio ranged from a high of 0.82 in Q1 2022 and a low of 0.07 during Q3 2025
- Its 5-year average for Equity Ratio is 0.62, with a median of 0.7 in 2022.
- As far as peak fluctuations go, Editas Medicine's Equity Ratio skyrocketed by 6269.16% in 2021, and later plummeted by 8756.36% in 2025.
- Over the past 5 years, Editas Medicine's Equity Ratio (Quarter) stood at 0.82 in 2021, then decreased by 14.19% to 0.7 in 2022, then decreased by 0.27% to 0.7 in 2023, then plummeted by 43.79% to 0.39 in 2024, then tumbled by 83.04% to 0.07 in 2025.
- Its Equity Ratio stands at 0.07 for Q3 2025, versus 0.09 for Q2 2025 and 0.24 for Q1 2025.